Applied Biosystems/MDS Sciex Win Patent Suit Against Micromass.Business Editors/Health & Medical Writers BIOWIRE2K FOSTER CITY, Calif. & TORONTO--(BW HealthWire)--March 15, 2002 Applied Biosystems (NYSE NYSE See: New York Stock Exchange :ABI Abi (ā`bī) [short for Abijah], in the Bible, King Hezekiah's mother. (Application Binary Interface) A specification for a specific hardware platform combined with the operating system. ), an Applera Corporation business, and MDS MDS, n See temporomandibular pain-dysfunction syndrome. MDS 1 Maternal deprivation syndrome, see there 2 Myelodysplastic syndrome, see there Inc. (TSE See Tokyo Stock Exchange. TSE 1. See Tokyo Stock Exchange (TSE). 2. See Toronto Stock Exchange (TSE). :MDS; NYSE:MDZ MDZ Mendez MDZ Moskauer Deutsche Zeitung (Moscow German newspaper) MDZ Maritime Defense Zone MDZ Musik Der Zukunft (music label & community) MDZ Mendoza, Mendoza, Argentina - El Plumerillo ), together with their Applied Biosystems/MDS Sciex Instruments partnership, today announced that the Federal District Court in Wilmington, DE has ruled in favor of Applied Biosystems and MDS Inc. in a patent infringement patent infringement n. the manufacture and/or use of an invention or improvement for which someone else owns a patent issued by the government, without obtaining permission of the owner of the patent by contract, license or waiver. lawsuit against Micromass U.K. Ltd. and its U.S. subsidiary, Micromass, Inc., both divisions of Waters Corporation. The Micromass Quattro Ultima(TM) systems, including the MassTRANSIT(TM) version introduced in March 2001, were found to infringe U.S. Patent No. 4,963,736. The patent covers technology for triple quadrupole A quadrupole is one of a sequence of configurations of electric charge or gravitational mass that can exist in ideal form, but it is usually just part of a multipole expansion of a more complex structure reflecting various orders of complexity. mass spectrometers. The jury awarded damages in the amount of $47.5 million to Applied Biosystems and MDS Inc. The lawsuit was originally filed on February 18, 2000. The court is expected to meet next week to enter the final judgment. "We are very pleased with the court's ruling today," said Michael W. Hunkapiller, Ph.D., President of Applied Biosystems. "Our scientific leadership in the area of triple quadrupole mass spectrometry mass spectrometry or mass spectroscopy Analytic technique by which chemical substances are identified by sorting gaseous ions by mass using electric and magnetic fields. is the result of significant investments in research and development made over the last decade. Today's ruling upholds the patents we have developed over this time and our leadership in this technology area," said Andy Boorn, Ph.D., President of MDS Sciex. About Applera Corporation and Applied Biosystems Applera Corporation comprises two operating groups. The Applied Biosystems Group develops and markets instrument-based systems, reagents, software, and contract services to the life science industry and research community. Customers use these tools to analyze nucleic acids (DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. and RNA RNA: see nucleic acid. RNA in full ribonucleic acid One of the two main types of nucleic acid (the other being DNA), which functions in cellular protein synthesis in all living cells and replaces DNA as the carrier of genetic ), small molecules, and proteins to make scientific discoveries, leading to the development of new pharmaceuticals, and to conduct standardized testing. Applied Biosystems is headquartered in Foster City, CA, and reported sales of $1.6 billion during fiscal 2001. The Celera Genomics Group (NYSE:CRA See Community Reinvestment Act. ), headquartered in Rockville, MD, is engaged principally in integrating advanced technologies to create therapeutic discovery and development capabilities for internal use and for its customers and collaborators. Celera's businesses are its online information business and its therapeutics discovery business. The online information business is a leading provider of information based on the human genome and other biological and medical information. Through the therapeutic discovery business, Celera intends to leverage its genomic and proteomic capabilities to identify drug targets and diagnostic marker candidates, and to discover novel therapeutic candidates. Celera Diagnostics, a joint venture between Applied Biosystems and Celera Genomics, is focused on discovery, development, and commercialization of novel diagnostics tests. Information about Applera Corporation, including reports and other information filed by the company with the Securities and Exchange Commission, is available on the World Wide Web at www.applera.com, or by telephoning 800.762.6923. Information about Applied Biosystems is available on the World Wide Web at www.appliedbiosystems.com. About MDS Sciex and MDS Inc. MDS Sciex is the analytical instrumentation division of MDS Inc. (NYSE: MDZ; TSE: MDS) MDS Inc. is an international health and life sciences company with revenues of $1.6B in 2001. Its products and services include: laboratory testing, imaging agents for nuclear medicine testing, sterilization systems for medical and consumer products, research and clinical development services for planning and delivery of cancer treatment, analytical instruments to assist in the development of new drugs, and medical/surgical supplies. MDS employs more than 10,000 highly skilled people at its global operations on four continents. Detailed information about the company is available at the MDS Web site at www.mdsintl.com. Note to Editors: Applied Biosystems, Celera, Celera Diagnostics and Celera Genomics are registered trademarks of Applera Corporation or its subsidiaries in the U.S. and certain other countries. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion